American Healthcare REIT vs Americold Realty Trust
AHR and COLD side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AHR and COLD compare
American Healthcare REIT is the larger company, worth 2.6 times as much as Americold Realty Trust ($12.6B against $4.8B).
On earnings, Americold Realty Trust is cheaper: it trades at 20.1× trailing earnings, against 118× for American Healthcare REIT.
American Healthcare REIT grew revenue faster over the last twelve months (21.5% versus 1.3% for Americold Realty Trust).
Americold Realty Trust keeps more of each dollar of sales as profit, with a net margin of 9.0% compared with 3.6% at American Healthcare REIT.
Both pay dividends: American Healthcare REIT yields 1.7% and Americold Realty Trust 5.5%.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AHR | COLD |
|---|---|---|
| Size and price | ||
| Market cap | $12.6B | $4.8B |
| Share price | $57.78 | $16.69 |
| Change, 1 year | 20.7% | 51.0% |
| Change, 5 years | – | −48.1% |
| Beta (5Y) | 0.44 | 0.72 |
| Employees | 121 | 13K |
| StockData Score | ||
| Total score | 11 | 11 |
| Valuation score | 0 | 4 (better) |
| Growth score | 5 (better) | 1 |
| Performance score | 3 | 3 |
| Health score | 2 (better) | 0 |
| Dividend score | 1 | 3 (better) |
| Valuation | ||
| P/E | 118× | 20.1× (better) |
| P/S | 4.7× | 1.8× (better) |
| P/B | 2.3× | 1.6× (better) |
| EV/EBITDA | 15.1× | 6.0× (better) |
| FCF yield | – | −2.8% |
| Fair value | $23.44 | $28.68 |
| Margin of safety | −146% | 41.8% (better) |
| Growth | ||
| Revenue growth (TTM) | 21.5% (better) | 1.3% |
| Revenue growth, 5Y average | 16.2% (better) | 5.5% |
| Net income growth (TTM) | 253% | – |
| EPS growth (TTM) | 250% | – |
| EPS growth, 5Y average | 53.1% | – |
| Profitability | ||
| Gross margin | 22.1% | 32.2% (better) |
| Operating margin | 20.2% (better) | 15.1% |
| Net margin | 3.6% | 9.0% (better) |
| FCF margin | – | −5.1% |
| Return on equity | 2.3% | 7.9% (better) |
| Return on invested capital | 13.7% (better) | 13.2% |
| Financial health | ||
| Interest coverage | 7.2× (better) | 2.4× |
| Altman Z-score | 4.14 (better) | 0.69 |
| Piotroski F-score | 7 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 1.7% | 5.5% (better) |
| Payout ratio | 193% | 111% |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 3.1% | – |
| Buyback yield | −23.6% | – |
| Shareholder yield | −21.9% | 5.5% (better) |
| Ownership | ||
| Held by institutions | 103% | 109% |
| Held by insiders | 0.63% | 10.4% |
| Insider net buying, 12 months | −$4.6M | −$25.4K (better) |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 15.5% | 11.4% |
Go deeper
- AHR stock overview
- AHR income statement
- AHR valuation and score
- COLD stock overview
- COLD income statement
- COLD valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.